Haisco Pharmaceutical Group Statistics

Total Valuation

Haisco Pharmaceutical Group has a market cap or net worth of CNY 36.22 billion. The enterprise value is 36.99 billion.

Market Cap	36.22B
Enterprise Value	36.99B

Important Dates

The last earnings date was Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	Sep 18, 2024

Share Statistics

Haisco Pharmaceutical Group has 1.11 billion shares outstanding. The number of shares has increased by 1.13% in one year.

Current Share Class	n/a
Shares Outstanding	1.11B
Shares Change (YoY)	+1.13%
Shares Change (QoQ)	+5.65%
Owned by Insiders (%)	74.68%
Owned by Institutions (%)	9.10%
Float	270.88M

Valuation Ratios

The trailing PE ratio is 75.57 and the forward PE ratio is 57.15.

PE Ratio	75.57
Forward PE	57.15
PS Ratio	9.67
PB Ratio	8.85
P/TBV Ratio	n/a
P/FCF Ratio	374.12
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.45, with an EV/FCF ratio of 382.13.

EV / Earnings	77.68
EV / Sales	9.94
EV / EBITDA	59.45
EV / EBIT	97.35
EV / FCF	382.13

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.50.

Current Ratio	1.99
Quick Ratio	1.72
Debt / Equity	0.50
Debt / EBITDA	3.33
Debt / FCF	21.42
Interest Coverage	9.73

Financial Efficiency

Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 3.98%.

Return on Equity (ROE)	13.22%
Return on Assets (ROA)	3.62%
Return on Capital (ROIC)	3.98%
Revenue Per Employee	683,255
Profits Per Employee	87,406
Employee Count	5,448
Asset Turnover	0.57
Inventory Turnover	3.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.47% in the last 52 weeks. The beta is 0.08, so Haisco Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	+43.47%
50-Day Moving Average	34.67
200-Day Moving Average	29.57
Relative Strength Index (RSI)	37.75
Average Volume (20 Days)	5,083,503

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Haisco Pharmaceutical Group had revenue of CNY 3.72 billion and earned 476.19 million in profits. Earnings per share was 0.43.

Revenue	3.72B
Gross Profit	2.69B
Operating Income	380.00M
Pretax Income	587.46M
Net Income	476.19M
EBITDA	615.33M
EBIT	380.00M
Earnings Per Share (EPS)	0.43

Full Income Statement

Balance Sheet

The company has 1.29 billion in cash and 2.07 billion in debt, giving a net cash position of -786.31 million or -0.71 per share.

Cash & Cash Equivalents	1.29B
Total Debt	2.07B
Net Cash	-786.31M
Net Cash Per Share	-0.71
Equity (Book Value)	4.18B
Book Value Per Share	3.69
Working Capital	1.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 512.97 million and capital expenditures -416.16 million, giving a free cash flow of 96.81 million.

Operating Cash Flow	512.97M
Capital Expenditures	-416.16M
Free Cash Flow	96.81M
FCF Per Share	0.09

Full Cash Flow Statement

Margins

Gross margin is 72.17%, with operating and profit margins of 10.21% and 12.79%.

Gross Margin	72.17%
Operating Margin	10.21%
Pretax Margin	15.78%
Profit Margin	12.79%
EBITDA Margin	16.53%
EBIT Margin	10.21%
FCF Margin	2.60%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.86%.

Dividend Per Share	0.29
Dividend Yield	0.86%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	88.72%
Buyback Yield	-1.13%
Shareholder Yield	-0.27%
Earnings Yield	1.32%
FCF Yield	0.27%

Dividend Details

Stock Splits

The last stock split was on September 12, 2013. It was a forward split with a ratio of 1.35.

Last Split Date	Sep 12, 2013
Split Type	Forward
Split Ratio	1.35

Scores

Haisco Pharmaceutical Group has an Altman Z-Score of 7.97.

Altman Z-Score	7.97
Piotroski F-Score	n/a